This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2014 · senior author
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
The Lancet Oncology · 2012
Latest funding
- $4,314,242
Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)
CIHR · 2022 · Principal investigator
- $1,078,562
Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)
CIHR · 2022 · Principal investigator
2 publications.
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.
Maunsell E, Goss PE, Chlebowski RT, Ingle JN, Alés-Martínez JE, Sarto GE, Fabian CJ, Pujol P, Ruiz A, Cooke AL, Hendrix S, Thayer DW, Rowland KM, Dubé P, Spadafora S, Pruthi S, Lickley L, Ellard SL, Cheung AM, Wactawski-Wende J, Gelmon KA, Johnston D, Hiltz A, Brundage M, Pater JL, Tu D, Richardson H
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
Cheung AM, Tile L, Cardew S, Pruthi S, Robbins J, Tomlinson G, Kapral MK, Khosla S, Majumdar S, Erlandson M
Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)
Principal investigators: Cheung, Angela M; Ahmed, Sofia B; Allen, Upton D; Bhat, Mamatha; Boyd, Steven K; Crawley, Angela M; Dolatabadi, Elham; Fahim, Christine; Farkouh, Michael E; Feld, Jordan J; Fox, Susan; Furlan, Andrea D; Goligher, Ewan C; Hodgson, David C; Inman, Robert D; Juando Prats, Clara; Lamontagne, Francois; Langlois, Marc-Andre; Levin, Adeera; Mansfield, Avril; Manske, Sarah L; McMaster, W. Robert; Mylopoulos, Maria; Oza, Amit M; Papaioannou, Alexandra; Pinto, Andrew D; Quinn, Kieran L; Rahman, Proton; Razak, Fahad; Richard, Nicolas; Richardson, Harriet; Sander, Beate H; Sellmann, Susanna; Stelfox, Henry T; Straus, Sharon E; Tartaglia, Maria Carmela; Tobe, Sheldon W; Tomlinson, George A; Verma, Amol; Walmsley, Sharon L; Wu, Robert; Xu, Wei
Keywords: Adaptive Trials; Biostatistics; Clinical Trials; Hqp Development; Job Shadowing; Mentorship; Pedogagy; Training
Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)
Principal investigators: Cheung, Angela M; Ahmed, Sofia B; Allen, Upton D; Bhat, Mamatha; Boyd, Steven K; Crawley, Angela M; Dolatabadi, Elham; Fahim, Christine; Farkouh, Michael E; Feld, Jordan J; Fox, Susan; Furlan, Andrea D; Goligher, Ewan C; Hodgson, David C; Inman, Robert D; Juando Prats, Clara; Lamontagne, Francois; Langlois, Marc-Andre; Levin, Adeera; Mansfield, Avril; Manske, Sarah L; McMaster, W. Robert; Mylopoulos, Maria; Oza, Amit M; Papaioannou, Alexandra; Pinto, Andrew D; Quinn, Kieran L; Rahman, Proton; Razak, Fahad; Richard, Nicolas; Richardson, Harriet; Sander, Beate H; Sellmann, Susanna; Stelfox, Henry T; Straus, Sharon E; Tartaglia, Maria Carmela; Tobe, Sheldon W; Tomlinson, George A; Verma, Amol; Walmsley, Sharon L; Wu, Robert; Xu, Wei
Keywords: Adaptive Trials; Biostatistics; Clinical Trials; Hqp Development; Job Shadowing; Mentorship; Pedogagy; Training
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Biostatistics Division
- Oncology
- Cancer Care and Epidemiology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.